Working... Menu

Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02800811
Recruitment Status : Completed
First Posted : June 15, 2016
Last Update Posted : July 21, 2016
Information provided by (Responsible Party):
OSE Immunotherapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2016
  Actual Study Completion Date : July 2016